MC, Sankari A, Sharma S. StatPearls [Internet]. StatPearls Publishing; Treasure Island (FL): Aug 28, 2023. Pulmonary Function Tests. \[[PubMed: 29493964](https://pubmed.ncbi.nlm.nih.gov/29493964)\] 35. Nakatsuka Y, Handa T, Kokosi M, Tanizawa K, Puglisi S, Jacob J, Sokai A, Ikezoe K, Kanatani KT, Kubo T, Tomioka H, Taguchi Y, Nagai S, Chin K, Mishima M, Wells AU, Hirai T. The Clinical Significance of Body Weight Loss in Idiopathic Pulmonary Fibrosis Patients. Respiration. 2018;96(4):338-347. \[[PubMed: 30130749](https://pubmed.ncbi.nlm.nih.gov/30130749)\] 36. Walsh SLF. Imaging biomarkers and staging in IPF. Curr Opin Pulm Med. 2018 Sep;24(5):445-452. \[[PubMed: 30015679](https://pubmed.ncbi.nlm.nih.gov/30015679)\] 37. Mangaonkar AA, Patnaik MM. Short Telomere Syndromes in Clinical Practice: Bridging Bench and Bedside. Mayo Clin Proc. 2018 Jul;93(7):904-916. \[[PMC free article: PMC6035054](/pmc/articles/PMC6035054/)\] \[[PubMed: 29804726](https://pubmed.ncbi.nlm.nih.gov/29804726)\] 38. National Lung Screening Trial Research Team. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, Gareen IF, Gatsonis C, Marcus PM, Sicks JD. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011 Aug 04;365(5):395-409. \[[PMC free article: PMC4356534](/pmc/articles/PMC4356534/)\] \[[PubMed: 21714641](https://pubmed.ncbi.nlm.nih.gov/21714641)\] 39. Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, Kreuter M, Lynch DA, Maher TM, Martinez FJ, Molina-Molina M, Myers JL, Nicholson AG, Ryerson CJ, Strek ME, Troy LK, Wijsenbeek M, Mammen MJ, Hossain T, Bissell BD, Herman DD, Hon SM, Kheir F, Khor YH, Macrea M, Antoniou KM, Bouros D, Buendia-Roldan I, Caro F, Crestani B, Ho L, Morisset J, Olson AL, Podolanczuk A, Poletti V, Selman M, Ewing T, Jones S, Knight SL, Ghazipura M, Wilson KC. Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline. Am J Respir Crit Care Med. 2022 May 01;205(9):e18-e47. \[[PMC free article: PMC9851481](/pmc/articles/PMC9851481/)\] \[[PubMed: 35486072](https://pubmed.ncbi.nlm.nih.gov/35486072)\] 40. Lentz RJ, Argento AC, Colby TV, Rickman OB, Maldonado F. Transbronchial cryobiopsy for diffuse parenchymal lung disease: a state-of-the-art review of procedural techniques, current evidence, and future challenges. J Thorac Dis. 2017 Jul;9(7):2186-2203. \[[PMC free article: PMC5542930](/pmc/articles/PMC5542930/)\] \[[PubMed: 28840020](https://pubmed.ncbi.nlm.nih.gov/28840020)\] 41. Ravaglia C, Wells AU, Tomassetti S, Gurioli C, Gurioli C, Dubini A, Cavazza A, Colby TV, Piciucchi S, Puglisi S, Bosi M, Poletti V. Diagnostic yield and risk/benefit analysis of trans-bronchial lung cryobiopsy in diffuse parenchymal lung diseases: a large cohort of 699 patients. BMC Pulm Med. 2019 Jan 16;19(1):16. \[[PMC free article: PMC6335717](/pmc/articles/PMC6335717/)\] \[[PubMed: 30651103](https://pubmed.ncbi.nlm.nih.gov/30651103)\] 42. Furini F, Carnevale A, Casoni GL, Guerrini G, Cavagna L, Govoni M, Scir√© CA. The Role of the Multidisciplinary Evaluation of Interstitial Lung Diseases: Systematic